| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.1M | +7.9% |
| SG&A Expense | $1.7M | -44.2% |
| Operating Income | -$4.3M | +31.2% |
| Net Income | -$4.3M | +31.1% |
| EPS (Basic) | $0.16 | +166.7% |
| EPS (Diluted) | $0.16 | -33.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $351K | +59.5% |
| Current Assets | $394K | -2.0% |
| Total Assets | $2.3M | +6.0% |
| Current Liabilities | $1.3M | +256.9% |
| Total Liabilities | $1.3M | +201.8% |
| Stockholders' Equity | $946K | -44.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | +23.0% |
| Capital Expenditures | $18K | +0.0% |
| Investing Cash Flow | -$265K | +27.3% |
| Financing Cash Flow | $3.0M | +751.2% |
| Free Cash Flow | -$2.6M | +22.8% |